Clinical trials
Agammaglobulinemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 3 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 4 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Recruiting | 9 |
| Unknown status | 4 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CSL Behring | 5 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 4 |
| Kedrion S.p.A. | 3 |
| Grifols Therapeutics LLC | 2 |
| M.D. Anderson Cancer Center | 2 |
| Octapharma | 2 |
| Advanced Neurosciences Institute | 1 |
| Baxalta now part of Shire | 1 |
| Bio Products Laboratory | 1 |
| Brigham and Women's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Agammaglobulinemia | 38 |
| Primary Immunodeficiency Diseases | 11 |
| Common Variable Immunodeficiency | 9 |
| Immunologic Deficiency Syndromes | 8 |
| Infections | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Warts | 4 |
| IgG Deficiency | 3 |
| Multiple Sclerosis | 3 |
| Neutropenia | 3 |
Trials
Showing 26 to 38 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.